Table 3.
Improvement in Pain Symptoms at 1 and 3 Months† | Improvement in Nonpain Symptoms at 1 and 3 Months† | |||||
---|---|---|---|---|---|---|
Mean (SD) | Change—Effect Size‡ | Mean (SD) | Change—Effect Size‡ | |||
Depression Response* | Baseline | 1 Month | 3 Months | Baseline | 1 Month | 3 Months |
Remitters | 3.7 (1.9) | 0.6 | 0.6 | 6.1 (2.8) | 0.7 | 0.9 |
Partial responders | 4.6 (2.1) | 0.8 | 0.7 | 8.5 (2.9) | 0.9 | 1.0 |
Nonresponders | 5.0 (2.1) | 0.5 | 0.3 | 8.2 (2.8) | 0.5 | 0.4 |
Remitters were defined as having a Hopkins Symptom Checklist modified depression subscale (HSCL-20) score ≤0.5 after 3 months of antidepressant treatment, while partial responders had a≥50% improvement in SCL-20 score but not to a level≤0.5. Patients who did not meet either criterion were placed in the nonresponders group.
Patient Health Questionnaire physical symptom score for the 5-item pain score ranges from 0 (no pain) to 10 (worst pain), and for the 9-item nonpain score ranges from 0 (asymptomatic) to 18 (most symptomatic).
To standardize comparisons among domains, change was measured in effect size, which is the mean change divided by the pooled standard deviation for a measure.
SD, standard deviation.